Hanmi Science Co.,Ltd Logo

Hanmi Science Co.,Ltd

A holding company managing subsidiaries in the pharmaceutical and healthcare sectors.

008930 | KO

Overview

Corporate Details

ISIN(s):
KR7008930000
LEI:
Country:
South Korea
Address:
경기도 화성시 팔탄면 무하로 214 한미약품(주) 팔탄공단, 화성시

Description

Hanmi Science Co., Ltd. is a holding company that manages subsidiaries engaged in the pharmaceutical and healthcare sectors. Its principal operating subsidiary, Hanmi Pharmaceutical, is an R&D-centric biopharmaceutical company focused on the development of innovative new drugs. The group's integrated activities span from in-house research and development to the manufacturing and commercialization of a wide range of pharmaceutical products. A key strategic focus is the creation of novel therapies to address unmet medical needs, which are then provided to medical professionals.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-11 00:00
수시공시의무관련사항(공정공시)
Korean 6.3 KB
2024-03-04 00:00
소송등의판결ㆍ결정
Korean 5.4 KB
2024-03-04 00:00
주식등의대량보유상황보고서(일반)
Korean 193.6 KB
2024-03-04 00:00
주식등의대량보유상황보고서(일반)
Korean 191.3 KB
2024-02-27 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.5 KB
2024-02-26 00:00
소송등의제기ㆍ신청(경영권분쟁소송)
Korean 6.2 KB
2024-02-02 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 13.9 KB
2024-02-02 00:00
매출액또는손익구조30%(대규모법인은15%)이상변경(자회사의 주요경영사항)
Korean 15.2 KB
2024-02-02 00:00
최대주주등소유주식변동신고서
Korean 67.8 KB
2024-02-01 00:00
[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항)
Korean 12.9 KB
2024-01-31 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동(자회사의 주요경영사항)
Korean 11.9 KB
2024-01-26 00:00
[기재정정]주식등의대량보유상황보고서(일반)
Korean 388.7 KB
2024-01-26 00:00
[기재정정]주식등의대량보유상황보고서(일반)
Korean 389.2 KB
2024-01-26 00:00
자기주식취득결과보고서
Korean 56.5 KB
2024-01-26 00:00
결산실적공시예고(안내공시)
Korean 4.3 KB

Automate Your Workflow. Get a real-time feed of all Hanmi Science Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hanmi Science Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hanmi Science Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.